Parkman Healthcare Partners LLC Mirati Therapeutics, Inc. Transaction History

Parkman Healthcare Partners LLC

  • $736 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$39.16 - $88.71 $596,641 - $1.35 Million
-15,236 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$75.82 - $150.97 $176,054 - $350,552
2,322 Added 17.98%
15,236 $1.25 Million
Q4 2021

Feb 11, 2022
BUY
$132.01 - $190.29 $1.7 Million - $2.46 Million
12,914 New
12,914 $1.89 Million

Others Institutions Holding MRTX

# of Institutions
19
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email